DekaBank Deutsche Girozentrale’s Ionis Pharmaceuticals IONS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.78M	Hold	93,807	–	–	0.01%	509
2026 Q1	$6.92M	Hold	93,807	–	–	0.01%	510
2025 Q4	$4.3M	Hold	93,807	–	–	0.01%	613
2025 Q3	$5.99M	Hold	93,807	–	–	0.01%	545
2025 Q2	$3.72M	Hold	93,807	–	–	0.01%	632
2025 Q1	$2.87M	Hold	93,807	–	–	0.01%	665
2024 Q4	$3.32M	Hold	93,807	–	–	0.01%	654
2024 Q3	$3.8M	Hold	93,807	–	–	0.01%	640
2024 Q2	$4.42M	Hold	93,807	–	–	0.01%	610
2024 Q1	$4.16M	Buy	93,807 +2,193	+2%	+$105K	0.01%	613
2023 Q4	$4.61M	Hold	91,614	–	–	0.01%	595
2023 Q3	$4.24M	Buy	91,614 +1,614	+2%	+$66.6K	0.01%	574
2023 Q2	$3.71M	Sell	90,000 -75,000	-45%	-$2.88M	0.01%	611
2023 Q1	$5.72M	Buy	165,000 +12,000	+8%	+$451K	0.01%	520
2022 Q4	$5.7M	Buy	153,000 +28,224	+23%	+$1.19M	0.02%	511
2022 Q3	$5.5M	Hold	124,776	–	–	0.02%	501
2022 Q2	$4.65M	Hold	124,776	–	–	0.01%	549
2022 Q1	$4.45M	Buy	124,776 +15,300	+14%	+$501K	0.01%	591
2021 Q4	$3.35M	Buy	109,476 +1,900	+2%	+$59.8K	0.01%	659
2021 Q3	$3.61M	Hold	107,576	–	–	0.01%	607
2021 Q2	$4.26M	Sell	107,576 -9,819	-8%	-$385K	0.01%	562
2021 Q1	$5.24M	Buy	117,395 +1,245	+1%	+$69.4K	0.02%	473
2020 Q4	$6.63M	Buy	116,150 +6,594	+6%	+$329K	0.02%	391
2020 Q3	$5.25M	Buy	109,556 +101,478	+1,256%	+$5.64M	0.02%	400
2020 Q2	$476K	Buy	8,078 +179	+2%	+$9.96K	﹤0.01%	808
2020 Q1	$376K	Sell	7,899 -291	-4%	-$16.2K	﹤0.01%	813
2019 Q4	$489K	Buy	+8,190	New	+$488K	﹤0.01%	837
2019 Q3	–	Sell	-82,781	Closed	-$5.38M	–	1056
2019 Q2	$5.38M	Sell	82,781 -55,095	-40%	-$3.89M	0.03%	413
2019 Q1	$6.4M	Buy	137,876 +67,200	+95%	+$4.33M	0.04%	379
2018 Q4	$3.75M	Sell	70,676 -67,200	-49%	-$3.43M	0.02%	413
2018 Q3	$6.4M	Buy	137,876 +120,600	+698%	+$5.67M	0.04%	383
2018 Q2	$725K	Sell	17,276 -30,000	-63%	-$1.33M	﹤0.01%	832
2018 Q1	$2.17M	Sell	47,276 -6,000	-11%	-$305K	0.01%	556
2017 Q4	$2.53M	Hold	53,276	–	–	0.02%	509
2017 Q3	$2.53M	Hold	53,276	–	–	0.02%	513
2017 Q2	$2.76M	Buy	+53,276	New	+$2.48M	0.02%	487
2016 Q3	–	Sell	-3,900	Closed	-$91K	–	991
2016 Q2	$91K	Sell	3,900 -55,200	-93%	-$1.78M	﹤0.01%	928
2016 Q1	$2.29M	Sell	59,100 -16,200	-22%	-$658K	0.03%	435
2015 Q4	$4.58M	Buy	75,300 +600	+0.8%	+$32.4K	0.05%	337
2015 Q3	$3.02M	Buy	74,700 +4,900	+7%	+$254K	0.04%	400
2015 Q2	$4.02M	Buy	69,800 +1,100	+2%	+$69.9K	0.05%	344
2015 Q1	$4.37M	Sell	68,700 -29,400	-30%	-$1.99M	0.05%	339
2014 Q4	$6.06M	Sell	98,100 -18,800	-16%	-$928K	0.08%	269
2014 Q3	$4.54M	Buy	116,900 +49,500	+73%	+$1.75M	0.06%	299
2014 Q2	$2.32M	Sell	67,400 -2,500	-4%	-$78.7K	0.03%	396
2014 Q1	$3.02M	Buy	69,900 +4,200	+6%	+$204K	0.05%	327
2013 Q4	$2.62M	Buy	65,700 +2,600	+4%	+$92.6K	0.04%	288
2013 Q3	$2.37M	Buy	+63,100	New	+$1.88M	0.04%	295

Other funds holding IONS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

DekaBank Deutsche Girozentrale's IONS Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 93,807 shares worth $6.78M. The position accounts for 0.01% of the portfolio, ranked #509.

DekaBank Deutsche Girozentrale first reported a position in IONS in Q3 2013 and has held it in 48 quarters since. The position peaked at $6.92M in Q1 2026. 229 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

DekaBank Deutsche Girozentrale held 93,807 shares of Ionis Pharmaceuticals worth $6.78M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
Ionis Pharmaceuticals made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #509 holding.
DekaBank Deutsche Girozentrale first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 48 quarters since.
DekaBank Deutsche Girozentrale's Ionis Pharmaceuticals position peaked at $6.92M in Q1 2026.
229 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.